Effect of Anti-Hypertensive Drug Atenolol on Liver Function by Evaluating ALT levels

Maria Fareed Siddiqui, Mehreen Rasheed, Ahmad Alwazzan, S. Sarwar
{"title":"Effect of Anti-Hypertensive Drug Atenolol on Liver Function by Evaluating ALT levels","authors":"Maria Fareed Siddiqui, Mehreen Rasheed, Ahmad Alwazzan, S. Sarwar","doi":"10.54393/fbt.v3i01.36","DOIUrl":null,"url":null,"abstract":"Hypertension is one of the major causes of cardiovascular and renal pathologies and it is mainly characterized by high blood pressure in blood vessels. Many drugs have been developed to treat hypertension, but these drugs have several side effects. Atenolol belongs to the beta blocker drug class and is used to treat hypertension and cardiovascular diseases. It is an anti-beta-adrenergic agent which inhibits beta receptors in the heart to decrease blood pressure. It has several side effects including hepatic dysfunctions. Objective: To analyze the effects of atenolol on hepatic dysfunction by evaluating the ALT level in patients taking either atenolol alone or in combination with other hypertensive drugs. Methods: The change in ALT levels were measured upon treatment of atenolol alone or in combination with other anti-hypertensive drugs. Out of selected 80 patients, 43 had been taking atenolol alone, 37 were taking atenolol in combination with other anti-hypertensive drugs and 20 were healthy controls. Micro-laboratory tests were performed for measuring the ALT levels. Results: Atenolol did not affect the ALT levels of any group, neither alone nor in combination with other hypertensive drugs. Conclusions: Atenolol may cause hepatic dysfunction but according to this study it does not cause change in ALT level of blood and ALT is not elevated in all liver dysfunction as have been reported earlier so it didn’t diminish the chance of effect of atenolol on liver functions. Further this study may be employed on larger patient groups for strengthening the outcomes of this study.","PeriodicalId":114319,"journal":{"name":"Futuristic Biotechnology","volume":"46 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Futuristic Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54393/fbt.v3i01.36","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Hypertension is one of the major causes of cardiovascular and renal pathologies and it is mainly characterized by high blood pressure in blood vessels. Many drugs have been developed to treat hypertension, but these drugs have several side effects. Atenolol belongs to the beta blocker drug class and is used to treat hypertension and cardiovascular diseases. It is an anti-beta-adrenergic agent which inhibits beta receptors in the heart to decrease blood pressure. It has several side effects including hepatic dysfunctions. Objective: To analyze the effects of atenolol on hepatic dysfunction by evaluating the ALT level in patients taking either atenolol alone or in combination with other hypertensive drugs. Methods: The change in ALT levels were measured upon treatment of atenolol alone or in combination with other anti-hypertensive drugs. Out of selected 80 patients, 43 had been taking atenolol alone, 37 were taking atenolol in combination with other anti-hypertensive drugs and 20 were healthy controls. Micro-laboratory tests were performed for measuring the ALT levels. Results: Atenolol did not affect the ALT levels of any group, neither alone nor in combination with other hypertensive drugs. Conclusions: Atenolol may cause hepatic dysfunction but according to this study it does not cause change in ALT level of blood and ALT is not elevated in all liver dysfunction as have been reported earlier so it didn’t diminish the chance of effect of atenolol on liver functions. Further this study may be employed on larger patient groups for strengthening the outcomes of this study.
抗高血压药物阿替洛尔通过评估ALT水平对肝功能的影响
高血压是引起心血管和肾脏病变的主要原因之一,主要表现为血管内血压升高。已经开发出许多治疗高血压的药物,但这些药物有一些副作用。阿替洛尔属于受体阻滞剂类药物,用于治疗高血压和心血管疾病。它是一种抗肾上腺素能药物,可以抑制心脏中的受体以降低血压。它有一些副作用,包括肝功能障碍。目的:通过评价阿替洛尔单用或联用降压药患者的ALT水平,分析阿替洛尔对肝功能障碍的影响。方法:观察阿替洛尔单用或联用抗高血压药物时ALT水平的变化。80例患者中,43例单独服用阿替洛尔,37例与其他抗高血压药物联合服用,20例为健康对照。显微实验室检测ALT水平。结果:阿替洛尔单独或与其他降压药合用均不影响各组患者的ALT水平。结论:阿替洛尔可能引起肝功能障碍,但根据本研究,阿替洛尔不会引起血液中ALT水平的变化,ALT也不会像之前报道的那样在所有肝功能障碍中升高,因此这并不会降低阿替洛尔对肝功能的影响。进一步,本研究可用于更大的患者群体,以加强本研究的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信